Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Pediatric low-grade gliomas: Next biologically driven steps

Title: Pediatric low-grade gliomas: Next biologically driven steps
Authors: Jones, DTW; Kieran, MW; Bouffet, E; Alexandrescu, S; Bandopadhayay, P; Bornhorst, M; Ellison, D; Fangusaro, J; Fisher, MJ; Foreman, N; Fouladi, M; Hargrave, D; Hawkins, C; Jabado, N; Massimino, M; Mueller, S; Perilongo, G; Schouten Van Meeteren, AYN; Tabori, U; Warren, K; Waanders, AJ; Walker, D; Weiss, W; Witt, O; Wright, K; Zhu, Y; Bowers, DC; Pfister, SM; Packer, RJ
Source: Neuro-Oncology , 20 (2) pp. 160-173. (2018)
Publication Year: 2018
Collection: University College London: UCL Discovery
Subject Terms: low-grade glioma; MAPK pathway; molecular diagnostics; neurooncology; pediatric brain tumor; targeted therapy
Description: Despite the fact that they are not typically life-threatening, low-grade gliomas (LGGs) remain a significant clinical challenge in pediatric neuro-oncology due to comorbidities associated with these tumors and/or their treatments, and their propensity to multiply recurs. LGGs, in total the most common brain tumors arising in childhood, can often become a chronic problem requiring decades of management. The Second International Consensus Conference on Pediatric Low-Grade Gliomas held in Padua, Italy in 2016 was convened in an attempt to advance the pace of translating biological discoveries on LGGs into meaningful clinical benefit. Topics discussed included: the implications of our growing biological understanding of the genomics underlying these tumors; the assessment of the model systems available; the implications of the molecular and histopathologic differences between adult and pediatric diffuse gliomas; and steps needed to expedite targeted therapy into late-stage clinical trials for newly diagnosed cases. Methods for the diagnostic assessment of alterations in the Ras/mitogen-activated protein kinase pathway, typical for these tumors, were also considered. While the overall tone was positive, with a consensus that progress is being and will continue to be made, the scale of the challenge presented by this complex group of tumors was also acknowledged. The conclusions and recommendations of the meeting panel are provided here as an outline of current thinking and a basis for further discussion.
Document Type: article in journal/newspaper
File Description: text
Language: English
Relation: https://discovery.ucl.ac.uk/id/eprint/10049510/
Availability: https://discovery.ucl.ac.uk/id/eprint/10049510/1/Pediatric%20Low-Grade%20Gliomas-%20Next%20Biologically%20Driven%20Steps%20Final%20accepted.pdf; https://discovery.ucl.ac.uk/id/eprint/10049510/
Rights: open
Accession Number: edsbas.C985AD4B
Database: BASE